Method of treatment of hereditary hemochromatosis

Details for Australian Patent Application No. 2007269536 (hide)

Owner Novartis AG

Inventors Rojkjaer, Lisa; Marks, Peter Wayne; Bodner, Janet Ellen; Nick, Hanspeter

Agent Davies Collison Cave

Pub. Number AU-B-2007269536

PCT Pub. Number WO2008/005624

Priority 60/803,049 24.05.06 US; 60/747,974 23.05.06 US; 60/835,658 04.08.06 US

Filing date 21 May 2007

Wipo publication date 10 January 2008

Acceptance publication date 30 June 2011

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 3/12 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

13 November 2008 PCT application entered the National Phase

  PCT publication WO2008/005624 Priority application(s): WO2008/005624

19 March 2009 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to include co-inventors Marks, Peter Wayne and Bodner, Janet Ellen

30 June 2011 Application Accepted

  Published as AU-B-2007269536

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007269540-Methods of using IGF1R and Abl kinase modulators

2007269530-Intravenous catheter insertion device and method of use